改良递增踏步试验在肺康复中的应用
本研究在稳定期慢性肺病患者中评估改良递增踏步试验(MIST)的信度、反应性及运动处方效用。MIST在中心和家庭按随机顺序进行,肺康复前后各测两次;家庭与中心记录步数的组内相关系数为0.954(95%CI=0.915-0.976),肺康复后效应量为0.34,最小可检测变化为7步。亚组研究中60%VO2peak对应MIST终末水平平均37%(95%CI=29-44)。
要点
- MIST在家庭与中心环境中的重测信度优秀,ICC=0.954(95%CI=0.915-0.976)。
- 肺康复后MIST反应性为小到中等效应量(0.34),最小可检测变化为7步。
- 60%VO2peak对应MIST终末水平平均37%,可用于家庭运动强度处方。
核心结论
- MIST在稳定期慢性呼吸系统疾病患者中信度良好且对肺康复有反应性,可在无法开展场地步行测试的环境中评估运动能力、制定运动训练并复评项目结局。
研究设计与样本
- 信度采用组内相关系数评估,反应性以效应量评估,最小重要差异采用分布法和锚定法评估。
- 亚组研究用便携式代谢系统测量MIST的生理反应,随后进行60%VO2peak的恒定步频测试以评估运动处方效用。
主要发现
- 家庭与中心环境中记录步数的组内相关系数为0.954(95%CI=0.915-0.976)。
- 肺康复后效应量为0.34,最小可检测变化为7步。
- 亚组研究中所有受试者均达到60%VO2peak,并在第4分钟达到稳态。
- 60%VO2peak对应MIST终末水平平均37%(95%CI=29-44)。
关键数值与推荐
- 信度:家庭与中心记录步数的ICC=0.954(95%CI=0.915-0.976)。
- 反应性:肺康复后效应量为0.34。
- 最小可检测变化为7步。
- 运动处方:60%VO2peak对应MIST终末水平平均37%(95%CI=29-44)。
临床怎么用
- 在无法进行场地步行测试的环境中,可用MIST评估运动能力并复评肺康复结局。
- 可依据60%VO2peak约对应MIST终末水平37%来设定恒定步频训练强度。
- MIST可在家庭实施,为全程居家肺康复提供运动测试与处方支持。
局限性
- 摘要未报告最小重要差异的具体数值及亚组样本量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A Modified Incremental Step Test (MIST) performed in the home may facilitate entirely home-based pulmonary rehabilitation programs. The aims of this study were to investigate the reliability and responsiveness, and the utility of the MIST for exercise prescription in people with stable chronic lung disease. METHODS: The MIST was undertaken at the center and home in random order, before and after pulmonary rehabilitation, with 2 tests at each time point. Reliability was assessed using intraclass correlation coefficient. Responsiveness was evaluated as effect size. The minimal important difference was appraised using distribution and anchor-based methods. In a substudy, physiological responses to MIST were measured by a portable metabolic system, followed by a constant step rate test at 60% of peak oxygen uptake (VO2peak), to evaluate utility for exercise prescription. RESULTS: Forty-six participants were recruited (29% of eligible candidates). There was excellent reliability for number of steps recorded in home- and center-based settings (intraclass correlation coefficient = 0.954, 95% CI = 0.915-0.976). A small-moderate effect size was demonstrated following pulmonary rehabilitation (0.34), and the minimal detectable change was 7 steps. All participants in the substudy achieved 60% of VO2peak and achieved steady state by the fourth minute, with 60% of VO2peak corresponding to a mean 37% (95% CI = 29-44) of the MIST final level. CONCLUSIONS: The MIST is reliable and responsive to pulmonary rehabilitation in people with stable chronic respiratory disease. It provides new opportunities to assess exercise capacity, prescribe exercise training, and reassess exercise program outcomes in environments where established field walking tests are not feasible. IMPACT: Pulmonary rehabilitation is a highly effective treatment that is underutilized worldwide. Home-based pulmonary rehabilitation may improve access for patients and deliver equivalent clinical outcomes but is limited by the availability of a robust exercise test that can be used at home to assess exercise capacity and prescribe training intensity. This study tested the clinimetric properties of the MIST and demonstrated a new way to assess exercise capacity, prescribe exercise training of an appropriate intensity, and reassess exercise capacity in environments where established field walking tests are not feasible.
引用
- Burge AT, Rodrigues JC, Abramson MJ, et al. Application of the Modified Incremental Step Test for Pulmonary Rehabilitation. Phys Ther. 2021. PMID: 33528020. doi:10.1093/ptj/pzab044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。